Stock Track | Senseonics Soars 5.07% Intraday on Acquisition of Eversense U.S. Assets from Ascensia

Stock Track
01/03

Senseonics Holdings Inc. (SENS) saw its stock surge 5.07% during intraday trading on Friday, reflecting strong investor optimism following the company's strategic acquisition announcement.

The medical technology company entered into a Master Asset Purchase Agreement with Ascensia Diabetes Care Holdings AG to acquire U.S. assets related to the marketing, selling, and distribution of the Eversense® continuous glucose monitoring (CGM) system. The deal, which closed on January 1, 2026, also includes plans for Senseonics to expand its footprint in Europe by acquiring additional Eversense-related assets in Italy, Germany, Spain, and Sweden by mid-2026, pending regulatory approvals.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10